Parkinson's Disease Study at Wake Research

Updated on 23 November 2020
motor symptoms


Now recruiting for a clinical study in patients with Parkinson's disease.

Do you, or someone you know, have Parkinson's disease?

Patient volunteers are needed for the Galliarde Study, a clinical research study to evaluate the safety of and how well the body handles ABBV-951.

  • ABBV-951 is an investigational product that is being developed for the control of motor symptoms - like tremors, slow movement and stiffness - due to Parkinson's disease (PD).
  • ABBV-951 has not been approved by regulatory agencies (such as the Food and Drug Administration [FDA] in the USA as an example).
  • ABBV-951 is a formulation of carbidopa and levodopa, which are medications commonly used to treat symptoms in PD.
  • ABBV-951 will be given daily through a continuous, 24-hour subcutaneous infusion. A pump device will gradually deliver it through a small plastic cannula (a type of needle) inserted under the skin. This is similar to how insulin can be delivered using an infusion pump for diabetics.

All eligible participants will receive the active study drug.



Qualified participants may receive:

  • Study-related medication at no cost
  • Study-related medical exams at no cost
  • Compensation up to $1,680 for time and travel

Condition Parkinson's disease
Clinical Study IdentifierTX227280
Last Modified on23 November 2020


Yes No Not Sure

Inclusion Criteria

Participants must be
Be 30 years of age or older
Have a diagnosis of levodopa-responsive PD
Have been taking a stable regimen of oral medications for PD containing levodopa, which has been unchanged for at least 30 days before receiving the study drug
Currently be on a therapy that is no longer working to control PD symptoms
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note